Primary Ciliary Dyskinesia: Do We Need to Test for Primary Immune Deficiency Routinely?

Area of Science:

• Immunology
• Pulmonology
• Genetics

Background:

• Primary Ciliary Dyskinesia (PCD) and predominantly antibody deficiencies (PAD) are significant causes of recurrent respiratory infections in children.
• Both conditions necessitate distinct management approaches.
• Investigating the co-occurrence of PCD and PAD is crucial for optimizing patient care.

Purpose of the Study:

• To assess the prevalence of predominantly antibody deficiencies (PAD) in patients diagnosed with Primary Ciliary Dyskinesia (PCD).
• To explore the relationship between the ultrastructural characteristics of PCD and the presence of immune disorders.

Main Methods:

• Sixty-two patients with PCD underwent comprehensive immunological assessments, including blood counts and immunoglobulin and lymphocyte subgroup analysis.
• PAD was defined as immunoglobulin levels more than 2 standard deviations below age-adjusted norms.
• Patients were categorized into Group 1 (immunological abnormalities) and Group 2 (normal immunological results).

Main Results:

• Over 41% of PCD patients (26 out of 62) exhibited immunological abnormalities, including lymphopenia and immunoglobulin deficiencies.
• No significant differences were observed between groups regarding pulmonary exacerbations, lung function (ppFEV1), chronic colonization, or ultrastructural phenotype.
• Patients with immune abnormalities received specialized follow-up, antibiotic prophylaxis, and vaccination planning.

Conclusions:

• Routine immunological screening in PCD patients is recommended due to the high prevalence of associated immune deficiencies.
• Early identification of PAD enables personalized treatment strategies, potentially improving respiratory health outcomes in PCD patients.